NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Hongliang Li
University of Oklahoma Health Sciences Center - Oklahoma City / United States
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 1595643
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Hongliang Li's MOST POPULAR ARTICLES
1-)
Prevalence of diabetes among men and women in ChinaW Yang, J Lu, J Weng, W Jia, L Ji, J Xiao, Z Shan, J Liu, H Tian, Q Ji, ...New England journal of medicine 362 (12), 1090-1101, 201080912010
2-)
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up studyG Li, P Zhang, J Wang, EW Gregg, W Yang, Q Gong, H Li, H Li, Y Jiang, ...The Lancet 371 (9626), 1783-1789, 200821322008
3-)
Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with …P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ...Circulation research 126 (12), 1671-1681, 202011432020
4-)
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyQ Gong, P Zhang, J Wang, J Ma, Y An, Y Chen, B Zhang, X Feng, H Li, ...The lancet Diabetes & endocrinology 7 (6), 452-461, 20195962019
5-)
Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta‐analysisF Zhou, J Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ...Hepatology 70 (4), 1119-1133, 20195912019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept